Biopharmaceutical Excipients Market Size & Growth Forecast 2027–2036, By Segments (Product), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Biopharmaceutical Excipients Market size was estimated at USD 3.4 billion in 2026 and is projected to grow at a 5.51% CAGR from 2027 to 2036, attaining USD 5.81 billion by 2036. The industry revenue for 2027 is assessed at USD 3.56 billion.
Get more details on this report
Request Free Sample ReportBiopharmaceutical Excipients Market Intelligence Snapshot
Regional Market Dynamics
- North America held a 36.04% market share in 2026, supported by established biopharmaceutical manufacturing, mature drug development infrastructure, and consistent demand for specialized formulation materials.
- Asia Pacific is projected to grow at a 6.33% CAGR as expanding biologics manufacturing and increasing participation in biopharmaceutical development drive demand for advanced excipients that support efficient production.
Segment Momentum
- Solubilizers & Surfactants/Emulsifiers captured 39.49% of the market in 2026 because they play a critical role in improving formulation stability, dispersion, and delivery performance across biopharmaceutical production processes.
- Polyols are the fastest-growing segment as manufacturers increasingly adopt excipients that help protect sensitive biological materials and support stability in advanced biopharmaceutical formulations.
Market Expansion Drivers
- Rapid expansion of biologics and biosimilars increasing demand for advanced formulation stabilizing excipients.
- Increasing complexity of injectable and gene therapies driving need for specialized surfactants and stabilizers.
- Growing mRNA and cell therapy pipelines accelerating adoption of next-generation delivery excipient systems.
Leading Market Participants
- Major players in the biopharmaceutical excipients market include Merck KGaA (Germany), BASF SE (Germany), Evonik Industries AG (Germany), Roquette Frères S.A. (France), Colorcon Inc. (United States), DFE Pharma GmbH & Co. KG (Germany), Clariant AG (Switzerland), IMCD N.V. (Netherlands), Associated British Foods plc (United Kingdom), J. RETTENMAIER & SÖHNE GmbH + Co KG (Germany).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 3.4 billion
- 2027 Estimated Market Size: USD 3.56 billion.
- Projected Market Size: USD 5.81 billion by 2036
- Growth Forecast: 5.51% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Solubilizes & Surfactants/Emulsifiers (Product)
- Emerging Opportunity Segment: Polyols (Product)
Market Growth Drivers and Industry Trends
Rapid expansion of biologics and biosimilars increasing demand for advanced formulation stabilizing excipients
Rapid expansion of biologics and biosimilars is driving the biopharmaceutical excipients market because these therapies often require carefully engineered formulations to maintain stability, quality, and therapeutic performance. Advanced excipients can help protect sensitive biological molecules against degradation and support consistent product characteristics during manufacturing and storage. As pharmaceutical pipelines increasingly incorporate biologic-based treatments, formulation developers require excipient systems capable of meeting the distinct stability and compatibility requirements associated with these products.
Increasing complexity of injectable and gene therapies driving need for specialized surfactants and stabilizers
Increasing complexity of injectable and gene therapies is supporting the biopharmaceutical excipients market by creating greater formulation challenges related to stability, aggregation, delivery, and product integrity. Specialized surfactants and stabilizers can help protect sensitive therapeutic components during processing and storage while maintaining formulation performance. The demanding requirements of injectable products and advanced gene-based therapies also encourage formulation developers to select excipients with specific functional properties suited to delicate biological materials.
Growing mRNA and cell therapy pipelines accelerating adoption of next-generation delivery excipient systems
Growing mRNA and cell therapy pipelines are expanding the biopharmaceutical excipients market through increased demand for advanced delivery and stabilization systems designed for emerging therapeutic modalities. These therapies can involve sensitive biological components that require specialized formulation strategies to preserve activity and facilitate effective delivery. Next-generation excipient systems can support the protection, processing, and delivery characteristics of such products, increasing their relevance across innovative drug development programs.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rapid expansion of biologics and biosimilars increasing demand for advanced formulation stabilizing excipients | 2.00% | High | North America, Europe | High | Near Term |
| Increasing complexity of injectable and gene therapies driving need for specialized surfactants and stabilizers | 1.80% | High | North America, Asia Pacific | High | Near Term |
| Growing mRNA and cell therapy pipelines accelerating adoption of next-generation delivery excipient systems | 1.60% | High | North America, Europe | Emerging | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
In the biopharmaceutical excipients market, North America accounted for 36.04% share in 2026, reflecting the region's advanced biopharmaceutical manufacturing ecosystem, strong research activity, and demand for high-quality excipients used in complex drug formulations. Extensive development of biologic therapies has increased the need for specialized materials that support drug stability, delivery, and manufacturing performance. Regulatory emphasis on product quality and manufacturing consistency, together with sophisticated production infrastructure, further supports regional demand for pharmaceutical-grade excipients.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is witnessing the fastest growth as biopharmaceutical production expands and healthcare infrastructure continues to improve. Increasing investment in biologics research, pharmaceutical manufacturing, and advanced drug delivery is creating broader applications for specialized excipients. The region's expanding patient population and growing access to innovative therapies are also encouraging greater biopharmaceutical development, while improvements in manufacturing standards and technical capabilities are supporting local adoption of high-performance excipient technologies.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Regulatory Quality AlignmentGermany emphasizes high-purity excipients, manufacturing consistency, and regulatory compliance for biopharmaceutical production. Suppliers in Germany work closely with pharmaceutical manufacturers to support formulation stability and efficient commercialization of biologic medicines.
France 🇫🇷
Specialized Excipient DevelopmentFrance advances the biopharmaceutical excipients market through specialized formulation expertise and collaboration between ingredient suppliers and pharmaceutical manufacturers. French companies prioritize excipients that support formulation performance, product stability, and regulatory expectations for biologic medicines.
Italy 🇮🇹
Flexible Supply PartnershipsItaly supports the biopharmaceutical excipients market by supplying specialized formulation materials for diverse pharmaceutical production requirements. Italian manufacturers focus on dependable quality systems and collaborative development that help optimize biologic formulation and manufacturing processes.
Japan 🇯🇵
Stability Enhancement ExpertiseJapan prioritizes excipients that improve biologic stability, storage performance, and manufacturing reliability. Japanese companies continue refining specialized excipient portfolios to address evolving formulation requirements across therapeutic proteins and advanced pharmaceutical products.
South Korea 🇰🇷
Biologics Manufacturing SupportSouth Korea aligns biopharmaceutical excipient development with expanding biologics manufacturing capacity and contract production activities. Suppliers in South Korea increasingly provide formulation materials designed to improve process efficiency and product consistency across modern biologic therapies.
United States 🇺🇸
Advanced Formulation SupportThe U.S. biopharmaceutical excipients market focuses on enabling complex biologics through innovative formulation materials and reliable supply partnerships. Companies in the U.S. continue expanding excipient development for injectable therapies, biologics, and advanced drug delivery platforms.
Segment Leadership and Growth Trends
Biopharmaceutical Excipients Market Share (%), by Product, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportProduct Segment Analysis: Solubilizes & Surfactants/Emulsifiers (Largest Segment) vs Polyols (Fastest-Growing Segment)
Solubilizes & Surfactants/Emulsifiers dominated the biopharmaceutical excipients market, accounting for a 39.49% share in 2026, supported by their essential role in improving the stability, solubility, dispersion, and overall performance of complex biopharmaceutical formulations. These excipients are particularly important for biologic products that can face challenges related to aggregation, poor aqueous solubility, and formulation instability. Their broad applicability across injectable and other advanced biologic formulations, combined with the increasing complexity of therapeutic molecules, continues to sustain demand for these functional excipients.
Polyols are expected to be the fastest-growing product segment, driven by their increasing use in stabilizing sensitive biological molecules and maintaining formulation integrity. These excipients can help protect proteins and other biologic components from stresses associated with processing, storage, and changes in formulation conditions. As biopharmaceutical developers place greater emphasis on product stability, extended shelf life, and reliable manufacturing performance, the need for excipients that provide effective protection without compromising therapeutic quality is supporting broader adoption of polyols.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Product | Solubilizes & Surfactants/Emulsifiers, Polyols, Carbohydrates | Solubilizes & Surfactants/Emulsifiers | Polyols |
Competitive Landscape and Market Positioning
Prominent players in the biopharmaceutical excipients market:
1. Merck KGaA (Germany)
2. BASF SE (Germany)
3. Evonik Industries AG (Germany)
4. Roquette Frères S.A. (France)
5. Colorcon Inc. (United States)
6. DFE Pharma GmbH & Co. KG (Germany)
7. Clariant AG (Switzerland)
8. IMCD N.V. (Netherlands)
9. Associated British Foods plc (United Kingdom)
10. J. RETTENMAIER & SÖHNE GmbH + Co KG (Germany)
The biopharmaceutical excipients market is experiencing significant innovation as biologic drug development continues to expand globally. Market participants are developing advanced excipient formulations designed to improve drug stability, delivery efficiency, and therapeutic performance. Increasing adoption of complex biologics and injectable therapies is also encouraging continuous investment in high-purity and multifunctional excipient technologies.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Merck KGaA (Germany) | |||||||
| BASF SE (Germany) | |||||||
| Evonik Industries AG (Germany) | |||||||
| Roquette Frères S.A. (France) | |||||||
| Colorcon Inc. (United States) | |||||||
| DFE Pharma GmbH & Co. KG (Germany) | |||||||
| Clariant AG (Switzerland) | |||||||
| IMCD N.V. (Netherlands) | |||||||
| Associated British Foods plc (United Kingdom) | |||||||
| J. RETTENMAIER & SÖHNE GmbH + Co KG (Germany). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Evonik | Oct-25 | Evonik expanded its EUDRACAP portfolio with a new series of colon-targeted functional capsules. These capsules utilize pH-dependent technology to enable localized drug release in the colon, addressing bioavailability challenges for sensitive biopharmaceutical formulations and strengthening the company's competitive position in the functional excipient segment for the biopharma sector. |
| BASF | Jun-25 | BASF opened a GMP Solution Center in Wyandotte, Michigan, focused on producing high-quality excipients and bioprocessing ingredients. The facility features advanced clean-room packaging and analytical testing capabilities, strategically enhancing BASF’s ability to provide regulatory-compliant, customized solutions for injectables and sensitive biologic therapies to meet growing global biopharmaceutical demand. |
| Nagase Viita Co., Ltd. | Jun-25 | Nagase Viita expanded its SOLBIOTE line with the launch of SUCROSE SG, a high-purity, low-endotoxin saccharide excipient. Designed specifically for injectable applications, this product offers critical stabilization for sensitive biopharmaceuticals, including mRNA vaccines and lipid nanoparticles, effectively supporting the stability and structural integrity requirements of next-generation biologic delivery systems. |
| Clariant | Nov-24 | Clariant launched its VitiPure LEX and Polyglykol S ranges, specifically engineered for sensitive biopharmaceutical applications. These specialized, low-endotoxin excipients address critical industry challenges related to API delivery and bioavailability, providing the necessary purity profiles for complex drug formulations and expanding the company’s footprint in the high-growth parenteral and biopharmaceutical excipient market. |
| Roquette | May-23 | Roquette introduced PEARLITOL ProTec, a specialized plant-based excipient designed to enhance the stability of moisture-sensitive active ingredients. By mitigating degradation risks for products like mRNA vaccines and injectable biologics, this innovation provides a critical solution for shelf-life management and performance in extreme conditions, reinforcing Roquette’s role in the specialized biologic excipient supply chain. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Biopharmaceutical Excipients Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Biologic Type | Monoclonal Antibodies, Recombinant Proteins, Vaccines, Cell & Gene Therapies |
| Route of Administration | Parenteral, Oral, Ophthalmic, Other Routes |
| End User | Pharmaceutical & Biotechnology Companies, Contract Manufacturing Organizations, Research & Academic Institutions |
Biopharmaceutical Excipients Market — Custom
| Custom Chapter | Custom Details |
|---|---|
| Biopharmaceutical Pipeline Impact Assessment |
|
| Raw Material Security and Supply Risk Assessment |
|
| Emerging Excipient Innovation Landscape |
|
Need a different cut of the data?
Request Custom ResearchHow much revenue does the biopharmaceutical excipients market generate?
What are the growth projections for the biopharmaceutical excipients industry?
How is the growth of biologics and biosimilars influencing excipient selection strategies?
Why are next-generation excipient systems gaining importance in advanced therapy development?
Why are solubilizers and surfactants/emulsifiers the largest product segment in the biopharmaceutical excipients market?
Which product segment is gaining momentum fastest in the biopharmaceutical excipients market?
Why is North America the leading biopharmaceutical excipients market?
What is fueling growth in the biopharmaceutical excipients market across Asia Pacific?
What are the prominent companies operating in the biopharmaceutical excipients landscape?
Our Clients
"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."
"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."
"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Chemicals & Materials Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Why It Matters | Reference |
|---|---|---|
| American Chemistry Council (ACC) | Chemicals, specialty chemicals, plastics, sustainability | www.americanchemistry.com |
| European Chemical Industry Council (Cefic) | European chemical industry, regulations, market trends | cefic.org |
| International Council of Chemical Associations (ICCA) | Global chemical industry and sustainability initiatives | icca-chem.org |
| European Chemicals Agency (ECHA) | REACH, CLP, chemical safety and regulations | echa.europa.eu |
| U.S. Environmental Protection Agency (EPA) | Chemicals, environmental regulations, waste management | www.epa.gov |
| ASTM International | Materials testing, polymers, metals, coatings, construction materials | www.astm.org |
| International Organization for Standardization (ISO) | Quality, material and manufacturing standards | www.iso.org |
| National Institute of Standards and Technology (NIST) | Advanced materials, manufacturing and measurement science | www.nist.gov |
| Plastics Industry Association (PLASTICS) | Plastics manufacturing, polymers and recycling | www.plasticsindustry.org |
| European Biplastics | Bioplastics and biodegradable materials | www.european-bioplastics.org |
| The Adhesive and Sealant Council (ASC) | Adhesives and sealants industry | www.ascouncil.org |
| National Association of Corrosion Engineers (AMPP) | Corrosion, protective coatings and materials performance | www.ampp.org |
| Society of Plastics Engineers (SPE) | Polymer engineering and plastics processing | www.4spe.org |
| International Fertilizer Association (IFA) | Fertilizers, crop nutrition and agricultural chemicals | www.fertilizer.org |
| CropLife International | Crop protection products and agricultural technologies | croplife.org |
| Packaging Europe | Packaging materials, sustainability and innovation | packagingeurope.com |
| Flexible Packaging Association (FPA) | Flexible packaging materials and technologies | www.flexpack.org |
| Battery Council International (BCI) | Battery materials, manufacturing and recycling | batterycouncil.org |
| International Copper Association (ICA) | Copper materials and industrial applications | internationalcopper.org |
| World Steel Association | Steel materials, production and market insights | worldsteel.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization